How severe is CVE-2023-29835?

CVE-2023-29835 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-29835 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-29835?

CVE-2023-29835 affects Wondershare Dr.fone. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-29835?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-29835 published?

CVE-2023-29835 was published on 2023-04-26 and last updated on 2026-06-17.

CVE-2023-29835

CVE-2023-29835 is a high-severity vulnerability in Wondershare Dr.fone with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: High (CVSS 3.x base score 7.8)
EPSS exploit prediction: 0% (30th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Wondershare Dr.fone
Published: 2023-04-26
Last modified: 2026-06-17

Description

Insecure Permission vulnerability found in Wondershare Dr.Fone v.12.9.6 allows a remote attacker to escalate privileges via the service permission function.

Frequently asked questions

What is CVE-2023-29835?: Insecure Permission vulnerability found in Wondershare Dr.Fone v.12.9.6 allows a remote attacker to escalate privileges via the service permission function.
How severe is CVE-2023-29835?: CVE-2023-29835 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-29835 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-29835?: CVE-2023-29835 affects Wondershare Dr.fone. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-29835?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-29835 published?: CVE-2023-29835 was published on 2023-04-26 and last updated on 2026-06-17.

References

https://github.com/IthacaLabs/Wondershare/tree/main/Dr.Fone

Affected products (1)

cpe:2.3:a:wondershare:dr.fone:12.9.6:*:*:*:*:windows:*:*

More vulnerabilities in Wondershare Dr.fone

CVE-2021-44596 — Critical (CVSS 9.8): Wondershare LTD Dr. Fone as of 2021-12-06 version is affected by Remote code execution. Due to software design flaws an…
CVE-2021-44595 — High (CVSS 8.8): Wondershare Dr. Fone Latest version as of 2021-12-06 is vulnerable to Incorrect Access Control. A normal user can send…
CVE-2022-50901 — High (CVSS 8.4): Wondershare Dr.Fone 11.4.9 contains an unquoted service path vulnerability in the DFWSIDService that allows local users…
CVE-2022-50900 — High (CVSS 8.4): Wondershare Dr.Fone 12.0.18 contains an unquoted service path vulnerability that allows local users to execute…
CVE-2023-27767 — High (CVSS 7.8): An issue found in Wondershare Technology Co.,Ltd Dr.Fone v.12.4.9 allows a remote attacker to execute arbitrary…
CVE-2023-27010 — High (CVSS 7.8): Wondershare Dr.Fone v12.9.6 was discovered to contain weak permissions for the service WsDrvInst. This vulnerability…

All CVEs affecting Wondershare Dr.fone →